What is Citius Oncology, Inc.'s expected volatility?

Citius Oncology, Inc. (CTOR) reported expected volatility of 85% in Q3 2025.

What does expected volatility mean?

A measure of the expected fluctuation in the company's stock price used to determine the fair value of share-based compensation awards. Higher volatility increases the calculated fair value of options, thereby increasing the recognized compensation expense.

Citius Oncology, Inc. CTOR Expected volatility

Expected volatility at other companies

Ollie's Bargain Outlet Holdings, Inc.OLLI

44.3%-3.9pp

Utah Medical ProductsUTMD

31.1%-0.1pp

UMH

UMH PropertiesUMH

27.4%+0.1pp

Achieve Life SciencesACHV

76.6%-2.3pp

Monro, Inc.MNRO

35.3%-5.3pp

Healthcare Services GroupHCSG

42.1%+1.6pp

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s expected volatility.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s expected volatility?: Citius Oncology, Inc. (CTOR) reported expected volatility of 85% in Q3 2025.
What does expected volatility mean?: A measure of the expected fluctuation in the company's stock price used to determine the fair value of share-based compensation awards. Higher volatility increases the calculated fair value of options, thereby increasing the recognized compensation expense.